Disease management interventions for heart failure
58 results
1 - 58
Disease management interventions for heart failure
Disease management interventions for heart failure - Chronic heart failure
- Structured telephone support or non‐invasive telemonitoring for patients with heart failure
Yearly BNP screening may decrease morbidity from heart failure- mHealth education interventions in heart failure
- Pharmacological interventions for heart failure in people with chronic kidney disease
- Psychological interventions for depression and anxiety in patients with coronary heart disease, heart failure or atrial fibrillation
- Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews
- Dietary interventions for adults with chronic kidney disease
- Exercise‐based cardiac rehabilitation for adults with heart failure
- Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases: Cochrane systematic review
- Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases
- Ventricular tachycardia
- Management of acute atrial fibrillation
- Automated telephone communication systems for preventive healthcare and management of long‐term conditions
- Oxygen therapy for dyspnoea in adults: Cochrane systematic review
- ACC/AHA guideline for the management of patients with chronic coronary disease
- Natriuretic peptide‐guided treatment for the prevention of cardiovascular events in patients without heart failure
- Endovascular versus open surgical repair for complicated chronic Type B aortic dissection
- Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
- Hospitalist-surgeon comanagement = no change in outcomes, but higher provider satisfaction
- COVID-19 research briefs: Wuhan patient outcomes, and new Infectious Disease Society of America treatment guidelines
- Personalised care planning for adults with chronic or long‐term health conditions
- Hypoxia‐inducible factor stabilisers for the anaemia of chronic kidney disease
- The most common types of acquired adult valvular heart disease and associated murmurs
- Phosphodiesterase 5 inhibitors for pulmonary hypertension
- Interactive telemedicine: effects on professional practice and health care outcomes
- Glucagon‐like peptide 1 (GLP‐1) receptor agonists for people with chronic kidney disease and diabetes
- Palliative treatment
- Hospitalisation in short-stay units for adults with internal medicine diseases and conditions: Cochrane systematic review
- Healthcare workers' perceptions and experiences of primary healthcare integration: a scoping review of qualitative evidence
- Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation
- Treatment of chronic renal failure
- Community care navigation intervention for people who are at risk of unplanned hospital presentations
- Exercise training undertaken by people within 12 months of lung resection for non‐small cell lung cancer
- Transfusion thresholds for guiding red blood cell transfusion
- Interventions for weight reduction in obesity to improve survival in women with endometrial cancer
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non‐diabetic chronic kidney disease
- Acute coronary syndrome
- Iron therapy for preoperative anaemia
- Erectile dysfunction
- Adult patient access to electronic health records